QA: Navidea Biopharmaceuticals Inc. in us_medicinal_products/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000810509_2018_Navidea_Biopharmaceuticals_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000810509, Navidea Biopharmaceuticals Inc.

  xvar xval
0 LiabilitiesNoncurrent 76,611
1 LiabilitiesCurrent 8,068,403
2 remainder_Liabilities 588,092
3 AssetsCurrent 13,832,405
4 AssetsNoncurrent 1,444,798
5 PropertyPlantAndEquipmentNet 236,701
6 Goodwill 458,156
7 remainder_Assets 4,809,376
8 GeneralAndAdministrativeExpense 11,169,951
9 ResearchAndDevelopmentExpense 4,513,842
10 remainder_Expenses -4,058,838
11 remainder_Revenues 1,810,437
12 remainder_NetIncome 84,760,374
13 remainder_ComprehensiveNetIncome -2,396
  yvar yval
0 Liabilities 8,733,106
1 Assets 20,781,436
2 Expenses 11,624,955
3 Revenues 1,810,437
4 StockholdersEquity 12,048,330
5 NetIncome 74,945,856
6 ComprehensiveNetIncome 74,944,658
7 BaseVar 63,856,352
8 EconomicCapitalRatio 5.77

Edgar->Model Mapping

Feature Distribution

Change over Time